Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a commercial-stage biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer, today announced that Dr. Claus Møller, MD, Ph.D., Chief Executive Officer of Y-mAbs Therapeutics will provide an overview and update on the company’s business at the virtual 39th Annual J.P. Morgan Healthcare Conference. The presentation will take place on Tuesday, January 12, 2021, at 10:00 AM Eastern Standard Time. The presentation can be accessed via a live webcast.
Read the full press release here